Remdesivir

MD News Daily - Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the COVID-19, in California

Gilead Applies for FDA Approval of Antiviral Drug Remdesivir

Aug 13, 2020 AM EDT

Gilead Sciences, Inc. recently announced it has applied to the US Food and Drug Administration the approval of remdesivir for COVID-19 treatment.

Can Interferons, the Frontline Protectors of the Body, Beat COVID-19?

Jul 10, 2020 AM EDT

Synthetic interferons administered prior and right after contagion may possibly tame the virus before it results in severe illness.

MD News Daily - Effective and not effective COVID-19 drugs

Which COVID-19 Drugs and Therapies Are Proven to Work, and Which Ones Aren't?

Jul 01, 2020 PM EDT

Keep in mind that this field of medicine is rapidly evolving as our understanding of the SARS-CoV-2 virus improves. Here's a list of treatments that have been tried and for which we have the best knowledge.

Drug Company Tests Remdesivir’s Inhaled Version as Potential Treatment for COVID-19

Jun 23, 2020 AM EDT

Gilead Sciences, an American biopharmaceutical firm, is soon starting to try remdesivir's inhalable version. Remdesivir is an antiviral medicine that has shown potential as a treatment for COVID-19 in early trials.